Close Menu

NEW YORK – Vancouver, British Columbia-based molecular diagnostics maker Fusion Genomics announced Thursday it has been awarded a one-year, $1 million grant from a Canadian research consortium. The funds will support a prospective clinical study using the firm's OneTest next-generation sequencing-based platform to diagnose respiratory tract infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.